Blood product required for the treatment of TTP patients
University Hospitals of Leicester NHS TrustcontractContracts Finder ↗Ref CF-1009100D0O000000rwimUAA1complete
Estimated value
£98k
Awarded value
£98k
Awarded 01 Aug 2022
Suppliers
1
Lots
1
1 awarded
Published
03 Aug 2022
Deadline 01 Jun 2022
Description
Octaplas, blood product required for the treatment of TTP patients. CMU National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Offer reference number: CM/PHS/19/5576
Scope
- Reference
- CF-1009100D0O000000rwimUAA1
- Total value
- £97,500 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2022 to 29 Jun 2024
- CPV classifications
- 33141510
Submission & procedure
- Submission deadline
- 01 Jun 2022, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£98k
Award date
01 Aug 2022
Contract start
30 Jun 2022
Contract end
29 Jun 2024
Awarded to